Fibrinogen deposition at the postischemic vessel wall promotes platelet adhesion during ischemia-reperfusion in vivo

Blood

Volumn 94, Issue 11, 1999, Pages 3829-3838

  Massberg, Steffen ^a,b   Enders, Georg ^a   De Matos, Francine Cláudia Melo ^a   Tomic, Luciana Inês Domschke ^a   Leiderer, Rosmarie ^a   Eisenmenger, Simone ^a   Messmer, Konrad ^a   Krombach, Fritz ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRINOGEN;

ANIMAL EXPERIMENT; ARTERY INTIMA PROLIFERATION; ARTICLE; BLOOD CLOTTING; ENDOTHELIUM CELL; FEMALE; ISCHEMIA; MOLECULAR RECOGNITION; MOUSE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; REPERFUSION INJURY; THROMBOCYTE ADHESION;

EID: 0033485324     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v94.11.3829     Document Type: Article

References (53)

1. Harris AG, Leiderer R, Peer F, Messmer K: Skeletal muscle microvascular and tissue injury after varying durations of ischemia. Am J Physiol 271:H2388, 1996
2. Nolte D, Hecht R, Schmid P, Botzlar A, Menger MD, Neumueller C, Sinowatz F, Vestweber D, Messmer K: Role of Mac-1 and ICAM-1 in ischemia-reperfusion injury in a microcirculation model of BALB/C mice. Am J Physiol 267:H1320, 1994
3. Lehr HA, Menger MD, Messmer K: Impact of leukocyte adhesion on myocardial ischemia/reperfusion injury: Conceivable mechanisms and proven facts. J Lab Clin Med 121:539, 1993
4. Ley K: Molecular mechanisms of leukocyte recruitment in the inflammatory process. Cardiovasc Res 32:733, 1996
5. Chintala MS, Bernardino V, Chiu PJ: Cyclic GMP but not cyclic AMP prevents renal platelet accumulation after ischemia-reperfusion in anesthetized rats. J Pharmacol Exp Ther 271:1203, 1994
6. Massberg S, Enders G, Leiderer R, Eisenmenger S, Vestweber D, Krombach F, Messmer K: Platelet-endothelial cell interactions during ischemia/reperfusion: The role of P-selectin. Blood 92:507, 1998
7. Marcus AJ: Pathways of oxygen utilization by stimulated platelets and leukocytes. Semin Hematol 16:188, 1979
8. Forde RC, Fitzgerald DJ: Reactive oxygen species and platelet activation in reperfusion injury. Circulation 95:787, 1997
9. Weyrich AS, Elstad MR, McEver RP, McIntyre TM, Moore KL, Morrissey JH, Prescott SM, Zimmerman GA: Activated platelets signal chemokine synthesis by human monocytes. J Clin Invest 97:1525, 1996
10. Bubel S, Wilhelm D, Entelmann M, Kirchner H, Kluter H: Chemokines in stored platelet concentrates. Transfusion 36:445, 1996
11. Deuel TF, Senior RM, Chang D, Griffin GL, Heinrikson RL, Kaiser ET: Platelet factor 4 is chemotactic for neutrophils and monocytes. Proc Natl Acad Sci USA 78:4584, 1981
12. Hervig TA, Farstad M: Human blood platelet serotonin studied in vitro: Endogenous serotonin may stimulate thrombin induced serotonin release in stored platelets. Platelets 7:53, 1996
13. Golino P, Ragni M, Cirilio P, Avvedimento VE, Feliciello A, Esposito N, Scognamiglio A, Trimarco B, Iaccarino G, Condorelli M, Chiariello M, Ambrosio G: Effects of tissue factor induced by oxygen free radicals on coronary flow during reperfusion. Nat Med 2:35, 1996
14. Yan SF, Zou YS, Gao Y, Zhai C, Mackman N, Lee SL, Milbrandt J, Pinsky D, Kisiel W, Stern D: Tissue factor transcription driven by Egr-1 is a critical mechanism of murine pulmonary fibrin deposition in hypoxia. Proc Natl Acad Sci USA 95:8298, 1998
15. Ogawa S, Gerlach H, Esposito C, Pasagian Macaulay A, Brett J, Stern D: Hypoxia modulates the barrier and coagulant function of cultured bovine endothelium. Increased monolayer permeability and induction of procoagulant properties. J Clin Invest 85:1090, 1990
16. Cadroy Y, Diquelou A, Dupouy D, Bossavy JP, Sakariassen KS, Sie P, Boneu B: The thrombomodulin/protein C/protein S anticoagulant pathway modulates the thrombogenic properties of the normal resting and stimulated endothelium. Arterioscler Thromb Vasc Biol 17:520, 1997
17. Okada Y, Copeland BR, Fitridge R, Koziol JA, del Zoppo GJ: Fibrin contributes to microvascular obstructions and parenchymal changes during early focal cerebral ischemia and reperfusion. Stroke 25:1847, 1994
18. Languino LR, Plescia J, Duperray A, Brian AA, Plow EF, Geltosky JE, Altieri DC: Fibrinogen mediates leukocyte adhesion to vascular endothelium through an ICAM-1-dependent pathway. Cell 73:1423, 1993
19. Sriramarao P, Languino LR, Altieri DC: Fibrinogen mediates leukocyte-endothelium bridging in vivo at low shear forces. Blood 88:3416, 1996
20. Savage B, Saldivar E, Ruggeri ZM: Initiation of platelet adhesion by arrest onto fibrinogen or translocation on von Willebrand factor. Cell 84:289, 1996
21. Bombeli T, Schwartz BR, Harlan JM: Adhesion of activated platelets to endothelial cells: Evidence for a GPIIbIIIa-dependent bridging mechanism and novel roles for endothelial intercellular adhesion molecule 1 (ICAM-1), alphavbeta3 integrin, and GPIbalpha. J Exp Med 187:329, 1998
22. Sligh JE Jr, Ballantyne CM, Rich SS, Hawkins HK, Smith CW, Bradley A, Beaudet AL: Inflammatory and immune responses are impaired in mice deficient in intercellular adhesion molecule I. Proc Natl Acad Sci USA 90:8529, 1993
23. Massberg S, Eisenmenger S, Enders G, Krombach F, Messmer K: Quantitative analysis of small intestinal microcirculation in the mouse. Res Exp Med (Berlin) 198:23, 1998
24. Witte S: Surface phenomena of coagulation factors in vivo, observed by fluorescence intravital microscopy. Ann NY Acad Sci 416:426, 1983
25. Adrie C, Bloch KD, Moreno PR, Hurford WE, Guerrero JL, Holt R, Zapol WM, Gold HK, Semigran MJ: Inhaled nitric oxide increases coronary artery patency after thrombolysis. Circulation 94:1919, 1996
26. Tschopp JF, Driscoll EM, Mu DX, Black SC, Pierschbacher MD, Lucchesi BR: Inhibition of coronary artery reocclusion after thrombolysis with an RGD-containing peptide with no significant effect on bleeding time. Coron Artery Dis 4:809, 1993
27. Nicolini FA, Lee P, Malycky JL, Lefkovits J, Kottke Marchant K, Plow EF, Topol EJ: Selective inhibition of factor Xa during thrombolytic therapy markedly improves coronary artery patency in a canine model of coronary thrombosis. Blood Coagul Fibrinol 7:39, 1996
28. Druid H, Rammer L: Protective effect on postischemic renal edema by anticoagulation. Nephron 60:319, 1992
29. Okada Y, Copeland BR, Mori E, Tung MM, Thomas WS, del Zoppo GJ: P-selectin and intercellular adhesion molecule-1 expression after focal brain ischemia and reperfusion. Stroke 25:202, 1994
30. Frenette PS, Moyna C, Hartwell DW, Lowe JB, Hynes RO, Wagner DD: Platelet-endothelial interactions in inflamed mesenteric venules. Blood 91:1318, 1998
31. Sakariassen KS, Holme PA, Orvim U, Barstad RM, Solum NO, Brosstad FR: Shear-induced platelet activation and platelet microparticle formation in native human blood. Thromb Res 92:S33, 1998 (suppl 2)
32. Goto S, Ikeda Y, Saldivar E, Ruggeri ZM: Distinct mechanisms of platelet aggregation as a consequence of different shearing flow conditions. J Clin Invest 101:479, 1998
33. Ikeda Y, Handa M, Kawano K, Kamata T, Murata M, Araki Y, Anbo H, Kawai Y, Watanabe K, Itagaki I, et al: The role of von Willebrand factor and fibrinogen in platelet aggregation under varying shear stress. J Clin Invest 87:1234, 1991
34. Duperray A, Languino LR, Plescia J, McDowall A, Hogg N, Craig AG, Berendt AR, Altieri DC: Molecular identification of a novel fibrinogen binding site on the first domain of ICAM-1 regulating leukocyte-endothelium bridging. J Biol Chem 272:435, 1997
35. Languino LR, Duperray A, Joganic KJ, Fornaro M, Thornton GB, Altieri DC: Regulation of leukocyte-endothelium interaction and leukocyte transendothelial migration by intercellular adhesion molecule 1-fibrinogen recognition. Proc Natl Acad Sci USA 92:1505, 1995
36. Bini A, Fenoglio JJ Jr, Mesa Tejada R, Kudryk B, Kaplan KL: Identification and distribution of fibrinogen, fibrin, and fibrin(ogen) degradation products in atherosclerosis. Use of monoclonal antibodies. Arteriosclerosis 9:109, 1989
37. Bini A, Fenoglio J Jr, Sobel J, Owen J, Fejgl M, Kaplan KL: Immunochemical characterization of fibrinogen, fibrin I, and fibrin II in human thrombi and atherosclerotic lesions. Blood 69:1038, 1987
38. Poston RN, Haskard DO, Coucher JR, Gall NP, Johnson Tidey RR: Expression of intercellular adhesion molecule-1 in atherosclerotic plaques. Am J Pathol 140:665, 1992
39. Ridker PM, Hennekens CH, Roitman Johnson B, Stampfer MJ, Allen J: Plasma concentration of soluble intercellular adhesion molecule and risks of future myocardial infarction in apparently healthy men. Lancet 351:88, 1998
40. Levenson J, Giral P, Razavian M, Gariepy J, Simon A: Fibrinogen and silent atherosclerosis in subjects with cardiovascular risk factors. Arterioscler Thromb Vasc Biol 15:1263, 1995
41. Wilhelmsen L, Svardsudd K, Korsan Bengtsen K, Larsson B, Welin L, Tibblin G: Fibrinogen as a risk factor for stroke and myocardial infarction. N Engl J Med 311:501, 1984
42. Hynes RO: Integrins: Versatility, modulation, and signaling in cell adhesion. Cell 69:11, 1992
43. Kirchhofer D, Sakariassen KS, Clozel M, Tschopp TB, Hadvary P, Nemerson Y, Baumgartner HR: Relationship between tissue factor expression and deposition of fibrin, platelets, and leukocytes on cultured endothelial cells under venous blood flow conditions. Blood 81:2050, 1993
44. Weiler Guettler H, Christie PD, Beeler DL, Healy AM, Hancock WW, Rayburn H, Edelberg JM, Rosenberg RD: A targeted point mutation in thrombomodulin generates viable mice with a prethrombotic state. J Clin Invest 101:1983, 1998
45. Gardiner EE, D'Souza SE: A mitogenic action for fibrinogen mediated through intercellular adhesion molecule-1. J Biol Chem 272:15474, 1997
46. Altieri DC, Duperray A, Plescia J, Thornton GB, Languino LR: Structural recognition of a novel fibrinogen gamma chain sequence (117-133) by intercellular adhesion molecule-1 mediates leukocyte-endothelium interaction. J Biol Chem 270:696, 1995
47. Theroux P, Kouz S, Roy L, Knudtson ML, Diodati JG, Marquis JF, Nasmith J, Fung AY, Boudreault JR, Delage F, Dupuis R, Kells C, Bokslag M, Steiner B, Rapold HJ: Platelet membrane receptor glycoprotein JIb/IIIa antagonism in unstable angina. The Canadian Lamifiban Study. Circulation 94:899, 1996
48. Power CA, Clemetson JM, Clemetson KJ, Wells TN: Chemokine and chemokine receptor mRNA expression in human platelets. Cytokine 7:479, 1995
49. Barry OP, Pratico D, Lawson JA, FitzGerald GA: Transcellular activation of platelets and endothelial cells by bioactive lipids in platelet microparticles. J Clin Invest 99:2118, 1997
50. Piccardoni P, Evangelista V, Piccoli A, Degaetano G, Walz A, Cerletti C: Thrombin activated human platelets release two NAP 2 variants that stimulate polymorphonuclear leukocytes. Thromb Haemost 76:780, 1996
51. Kaplanski G, Porat R, Aiura K, Erban JK, Gelfand JA, Dinarello CA: Activated platelets induce endothelial secretion of interleukin-8 in vitro via an interleukin-1-mediated event. Blood 81:2492, 1993
52. Hicks RC, Golledge J, Mir Hasseine R, Powell JT: Vasoactive effects of fibrinogen on saphenous vein. Nature 379:818, 1996
53. Henn V, Slupsky JR, Grafe M, Anagnostopoulos I, Forster R, Müller-Berghaus G, Kroczek RA: CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells. Nature 391:591, 1998